Pharmaceutical strategic consulting.
Helping pharma-biotech companies improve their market position to increase their value.
With more than 20 years of experience, we are a reference in the pharmaceutical market, offering the combination of our experience in the pharmaceutical business with a deep scientific knowledge.
More than 20 years developing business strategies, assessing and evaluating products and accompanying start-ups and laboratories in the launch of products.
Founded by Dr. Esperanza Regueras in 2004.
Dr. Esperanza Regueras holds a degree in Pharmacy from the University of Navarra, an MBA from IESE and a PhD in Pharmacy from the University of Navarra.
She has held various marketing and strategic management positions in national and multinational pharmaceutical laboratories.
Director and founder of Axis Pharma, she combines her leadership in the company with a solid academic career as a lecturer at the University of Navarra, where she teaches on the Master's Degree in Pharmaceutical Industry-Biotech.
She maintains a high level of scientific activity with the publication of scientific articles and her participation as a member of SEMDOR and editor of the journal MPJ.
Strategic consultancy: Analysis of market potential, market segmentation, identification of opportunities, design and definition of innovative and competitive products, positioning and re-positioning of products, preparation of forecasts, evaluation of the profitability of innovation projects.
Business development: evaluation of business opportunities for licensing-in or out negotiations.
Market studies: Market sizing and identification of segments and unmet needs.
Development of Business cases: a Business Case is a business case that compiles in a structured way the strategic analysis of a business to determine its viability and, if necessary, to define the optimal strategic and tactical approach as well as the expected returns.
Development and evaluation of scientific content
Extensive experience in all types of markets and segments.
Profound scientific knowledge.
Focused on results and success.
In-depth, ad-hoc and decision-useful analysis.
Long-term vision.
Own methodology in the elaboration of business cases and forecasting.
Involvement in each project working as part of the team.
Multinational Pharma-Biotech companies, national companies or start-ups
Evento: Barreras a la innovación: retos de las startups en el sector Pharma-Biotech
Axis Pharma
Dolor crónico: prevalencia en las consultas de Atención Primaria
Axis Pharma
Vacunas RNA contra Coronavirus: Composición y funcionamiento
Axis Pharma
Infographic | WORLD CANCER DAY By Sandra Gómez Nograro, Strategic Consultant of Axis Pharma
Axis Pharma
Esclerosis Múltiple: 'La enfermedad de las mil caras' Por Sandra Gómez Nograro, Strategic Consultant de Axis Pharma
Axis Pharma
Esperanza Regueras: 'Evitar la cronificación del dolor es fundamental para prevenir daños económicos'
Axis Pharma
Why I think a quick and reliable diagnostic test is going to make the difference in COVID-19
Axis Pharma
